Review



non-linear regression fitted to the data by graphpad prism v7.0  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GraphPad Software Inc non-linear regression fitted to the data by graphpad prism v7.0
    50% cytotoxic dose and effective dose (CC50 and EC50) of resveratrol against Venezuelan equine encephalitis virus (VEEV) in two distinct cell types. Vero ( A , B ) and U87MG ( C , D ) cells were treated with resveratrol at indicated concentrations (CC50) along with VEEV-TC-83 infection for 16 h at an MOI of 0.1 followed by measurement (EC50) of ( A , D ) cell viability and ( B , E ) replication of reporter VEEV-TC83luc quantified by cellular ATP and luciferase activity, respectively. The figures were plotted following the normalizing toward viral control groups. Viral control refers to no resveratrol-treated but VEEV-infected cells, while mock control was defined as cells treated with a solvent and without infection. ( E ) The CC50, EC50, and therapeutic index (TI) were estimated via non-linear regression with GraphPad Prism <t>v7.0</t> to determine the 50% cell viability and effective dose. Data were presented as means ± SEM.
    Non Linear Regression Fitted To The Data By Graphpad Prism V7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non-linear+regression+fitted+to+the+data+by+graphpad+prism+v7%2E0/prism+curve+fitting+software/pmc07918260-47-17-16
    Average 90 stars, based on 1 article reviews
    non-linear regression fitted to the data by graphpad prism v7.0 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Resveratrol Inhibits Venezuelan Equine Encephalitis Virus Infection by Interfering with the AKT/GSK Pathway"

    Article Title: Resveratrol Inhibits Venezuelan Equine Encephalitis Virus Infection by Interfering with the AKT/GSK Pathway

    Journal: Plants

    doi: 10.3390/plants10020346

    50% cytotoxic dose and effective dose (CC50 and EC50) of resveratrol against Venezuelan equine encephalitis virus (VEEV) in two distinct cell types. Vero ( A , B ) and U87MG ( C , D ) cells were treated with resveratrol at indicated concentrations (CC50) along with VEEV-TC-83 infection for 16 h at an MOI of 0.1 followed by measurement (EC50) of ( A , D ) cell viability and ( B , E ) replication of reporter VEEV-TC83luc quantified by cellular ATP and luciferase activity, respectively. The figures were plotted following the normalizing toward viral control groups. Viral control refers to no resveratrol-treated but VEEV-infected cells, while mock control was defined as cells treated with a solvent and without infection. ( E ) The CC50, EC50, and therapeutic index (TI) were estimated via non-linear regression with GraphPad Prism v7.0 to determine the 50% cell viability and effective dose. Data were presented as means ± SEM.
    Figure Legend Snippet: 50% cytotoxic dose and effective dose (CC50 and EC50) of resveratrol against Venezuelan equine encephalitis virus (VEEV) in two distinct cell types. Vero ( A , B ) and U87MG ( C , D ) cells were treated with resveratrol at indicated concentrations (CC50) along with VEEV-TC-83 infection for 16 h at an MOI of 0.1 followed by measurement (EC50) of ( A , D ) cell viability and ( B , E ) replication of reporter VEEV-TC83luc quantified by cellular ATP and luciferase activity, respectively. The figures were plotted following the normalizing toward viral control groups. Viral control refers to no resveratrol-treated but VEEV-infected cells, while mock control was defined as cells treated with a solvent and without infection. ( E ) The CC50, EC50, and therapeutic index (TI) were estimated via non-linear regression with GraphPad Prism v7.0 to determine the 50% cell viability and effective dose. Data were presented as means ± SEM.

    Techniques Used: Infection, Luciferase, Activity Assay

    Related Articles

    Concentration Assay:

    Article Title: Resveratrol Inhibits Venezuelan Equine Encephalitis Virus Infection by Interfering with the AKT/GSK Pathway
    Article Snippet: The 50% cytotoxic concentration (CC50) values were calculated via non-linear regression fitted to the data by GraphPad Prism v7.0.

    Infection:

    Article Title: Resveratrol Inhibits Venezuelan Equine Encephalitis Virus Infection by Interfering with the AKT/GSK Pathway
    Article Snippet: The 50% cytotoxic concentration (CC50) values were calculated via non-linear regression fitted to the data by GraphPad Prism v7.0.

    Luciferase:

    Article Title: Resveratrol Inhibits Venezuelan Equine Encephalitis Virus Infection by Interfering with the AKT/GSK Pathway
    Article Snippet: The 50% cytotoxic concentration (CC50) values were calculated via non-linear regression fitted to the data by GraphPad Prism v7.0.

    Activity Assay:

    Article Title: Resveratrol Inhibits Venezuelan Equine Encephalitis Virus Infection by Interfering with the AKT/GSK Pathway
    Article Snippet: The 50% cytotoxic concentration (CC50) values were calculated via non-linear regression fitted to the data by GraphPad Prism v7.0.



    Similar Products

    non-linear regression fitted to the data by graphpad prism v7.0  (GraphPad Software Inc)
    90
    GraphPad Software Inc non-linear regression fitted to the data by graphpad prism v7.0
    50% cytotoxic dose and effective dose (CC50 and EC50) of resveratrol against Venezuelan equine encephalitis virus (VEEV) in two distinct cell types. Vero ( A , B ) and U87MG ( C , D ) cells were treated with resveratrol at indicated concentrations (CC50) along with VEEV-TC-83 infection for 16 h at an MOI of 0.1 followed by measurement (EC50) of ( A , D ) cell viability and ( B , E ) replication of reporter VEEV-TC83luc quantified by cellular ATP and luciferase activity, respectively. The figures were plotted following the normalizing toward viral control groups. Viral control refers to no resveratrol-treated but VEEV-infected cells, while mock control was defined as cells treated with a solvent and without infection. ( E ) The CC50, EC50, and therapeutic index (TI) were estimated via non-linear regression with GraphPad Prism <t>v7.0</t> to determine the 50% cell viability and effective dose. Data were presented as means ± SEM.
    Non Linear Regression Fitted To The Data By Graphpad Prism V7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non-linear+regression+fitted+to+the+data+by+graphpad+prism+v7%2E0/prism+curve+fitting+software/pmc07918260-47-17-16
    Average 90 stars, based on 1 article reviews
    non-linear regression fitted to the data by graphpad prism v7.0 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    50% cytotoxic dose and effective dose (CC50 and EC50) of resveratrol against Venezuelan equine encephalitis virus (VEEV) in two distinct cell types. Vero ( A , B ) and U87MG ( C , D ) cells were treated with resveratrol at indicated concentrations (CC50) along with VEEV-TC-83 infection for 16 h at an MOI of 0.1 followed by measurement (EC50) of ( A , D ) cell viability and ( B , E ) replication of reporter VEEV-TC83luc quantified by cellular ATP and luciferase activity, respectively. The figures were plotted following the normalizing toward viral control groups. Viral control refers to no resveratrol-treated but VEEV-infected cells, while mock control was defined as cells treated with a solvent and without infection. ( E ) The CC50, EC50, and therapeutic index (TI) were estimated via non-linear regression with GraphPad Prism v7.0 to determine the 50% cell viability and effective dose. Data were presented as means ± SEM.

    Journal: Plants

    Article Title: Resveratrol Inhibits Venezuelan Equine Encephalitis Virus Infection by Interfering with the AKT/GSK Pathway

    doi: 10.3390/plants10020346

    Figure Lengend Snippet: 50% cytotoxic dose and effective dose (CC50 and EC50) of resveratrol against Venezuelan equine encephalitis virus (VEEV) in two distinct cell types. Vero ( A , B ) and U87MG ( C , D ) cells were treated with resveratrol at indicated concentrations (CC50) along with VEEV-TC-83 infection for 16 h at an MOI of 0.1 followed by measurement (EC50) of ( A , D ) cell viability and ( B , E ) replication of reporter VEEV-TC83luc quantified by cellular ATP and luciferase activity, respectively. The figures were plotted following the normalizing toward viral control groups. Viral control refers to no resveratrol-treated but VEEV-infected cells, while mock control was defined as cells treated with a solvent and without infection. ( E ) The CC50, EC50, and therapeutic index (TI) were estimated via non-linear regression with GraphPad Prism v7.0 to determine the 50% cell viability and effective dose. Data were presented as means ± SEM.

    Article Snippet: The 50% cytotoxic concentration (CC50) values were calculated via non-linear regression fitted to the data by GraphPad Prism v7.0.

    Techniques: Infection, Luciferase, Activity Assay